Rolf W Hartmann Selected Research

Fibrosis (Cirrhosis)

1/2017	Pharmacophore Modeling and in Silico/in Vitro Screening for Human Cytochrome P450 11B1 and Cytochrome P450 11B2 Inhibitors.
8/2015	Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
1/2015	Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase.
1/2015	1-Phenylsulfinyl-3-(pyridin-3-yl)naphthalen-2-ols: a new class of potent and selective aldosterone synthase inhibitors.
6/2014	Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
6/2014	Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
4/2011	Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives.
9/2009	Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo.
8/2008	Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
4/2006	Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rolf W Hartmann Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 04/2016 - 05/2003
19	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2002
17	Heart Failure 01/2017 - 06/2002
16	Fibrosis (Cirrhosis) 01/2017 - 04/2003
15	Neoplasms (Cancer) 01/2019 - 04/2002
12	Infections 10/2022 - 07/2009
12	Endometriosis 09/2019 - 11/2008
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 10/2006
11	Osteoporosis 09/2019 - 01/2011
8	Cushing Syndrome 01/2019 - 01/2011
6	Hypertension (High Blood Pressure) 11/2020 - 06/2014
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2005 - 01/2002
4	Bone Resorption 01/2019 - 08/2012
4	Pseudomonas Infections 01/2015 - 08/2013
3	Wounds and Injuries (Trauma) 10/2020 - 09/2014
3	Body Weight (Weight, Body) 10/2020 - 10/2006
3	Carcinoma (Carcinomatosis) 06/2010 - 10/2004
2	Bone Fractures (Bone Fracture) 01/2019 - 11/2011
2	Metabolic Diseases (Metabolic Disease) 01/2017 - 08/2011
2	Alzheimer Disease (Alzheimer's Disease) 04/2016 - 12/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015 - 04/2011
2	Hyperaldosteronism (Conn Syndrome) 04/2011 - 06/2002
1	Neglected Diseases 01/2022
1	Schistosomiasis (Bilharziasis) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Pulmonary Hypertension 11/2020
1	Erectile Dysfunction 11/2020
1	Wound Infection (Wound Infections) 10/2020
1	Adrenocortical Carcinoma 01/2020
1	Hyperplasia 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Postmenopausal Osteoporosis 01/2019

Drug/Important Bio-Agent (IBA)

21	EnzymesIBA 10/2022 - 01/2002
21	Estrogens (Estrogen)FDA Link 09/2019 - 06/2004
17	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2019 - 06/2002
15	AldosteroneIBA 01/2019 - 06/2002
14	AndrogensIBA 11/2017 - 01/2002
12	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 01/2019 - 12/2004
11	Oxidoreductases (Dehydrogenase)IBA 12/2021 - 01/2011
11	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2019 - 08/2010
10	Pharmaceutical PreparationsIBA 01/2022 - 03/2003
9	Aromatase (CYP19)IBA 01/2019 - 05/2003
9	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 05/2010
7	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 01/2011
6	Hormones (Hormone)IBA 07/2012 - 06/2004
5	SteroidsIBA 01/2020 - 03/2005
5	abirateroneIBA 11/2017 - 08/2008
4	AcidsIBA 10/2020 - 03/2005
4	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2019 - 12/2004
4	Testosterone (Sustanon)FDA Link 01/2019 - 01/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
3	Collagenases (Collagenase)FDA Link 01/2020 - 01/2017
3	Estrone FDA Link 09/2019 - 06/2004
3	Estrogen ReceptorsIBA 01/2019 - 06/2004
3	Biological ProductsIBA 01/2019 - 08/2008
3	SaltsIBA 09/2009 - 03/2005
3	PlatinumIBA 03/2007 - 06/2004
2	ZincIBA 10/2022 - 01/2018
2	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 01/2017
2	Blood Proteins (Serum Proteins)IBA 10/2020 - 06/2004
2	2-heptyl-3-hydroxy-4-quinoloneIBA 10/2020 - 01/2015
2	MineralocorticoidsIBA 01/2020 - 06/2014
2	Aromatase InhibitorsIBA 01/2015 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 05/2011
2	pyridineIBA 08/2013 - 04/2011
2	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 06/2004 - 06/2004
2	ethyleneIBA 06/2004 - 06/2004
2	DiaminesIBA 06/2004 - 06/2004
1	LactamsIBA 10/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 10/2022
1	Praziquantel (Biltricide)FDA Link 01/2022
1	cytochrome P-450 CYP121IBA 01/2021
1	Celecoxib (Celebrex)FDA Link 11/2020
1	Phosphodiesterase 5 InhibitorsIBA 11/2020
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2020
1	Bacterial RNAIBA 10/2020
1	AlginatesIBA 10/2020
1	clostebolIBA 01/2020
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2020
1	mestanoloneIBA 01/2020
1	HydrogenIBA 01/2020
1	Methenolone (Metenolone)IBA 01/2020
1	ColforsinIBA 01/2020
1	Pseudomonas aeruginosa pseudolysinIBA 01/2020
1	Oxymetholone (Anadrol)FDA Link 01/2020
1	Mesterolone (Proviron)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Sulfates (Sulfates, Inorganic)IBA 01/2020
1	estradiol 3-benzoate (estradiol benzoate)IBA 01/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	silmitasertibIBA 01/2019
1	N-dodecyl-L-lysine amideIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Hydroxysteroid DehydrogenasesIBA 12/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018

Therapy/Procedure

17	Therapeutics 01/2022 - 04/2003
2	Castration 01/2016 - 07/2013
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2019